| 2024-03-04 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 3,934 0.0064% | $41.86 | $164,664 | -16.33% | |
| 2023-03-02 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 1,370 0.0022% | $31.00 | $42,465 | -23.5% | |
| 2022-01-12 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 15,000 0.0297% | $51.85 | $777,684 | -44.59% | |
| 2021-12-03 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 10,000 0.021% | $53.56 | $535,637 | -43.67% | |
| 2021-09-03 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 20,000 0.0395% | $60.12 | $1.2M | -34.48% | |
| 2021-06-03 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 20,000 0.0442% | $46.87 | $937,390 | +10.58% | |
| 2021-03-15 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 16,390 0.0184% | $30.09 | $493,096 | -13.14% | |
| 2021-03-11 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 3,610 0.0042% | $31.08 | $112,186 | -11.4% | |
| 2021-03-08 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 20,000 0.0459% | $50.65 | $1.01M | +6.67% | |
| 2021-03-03 | Sale | Kymera Therapeutics, Inc. KYMR | Chief Financial Officer | 40,000 0.0892% | $44.78 | $1.79M | +17.27% |